

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States....
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 26, 2026
Q4 2025
Feb 26, 2026
Q3 2025
Nov 6, 2025